Pro Health Tips
Friday, 29 May 2020
Nilotinib Affects Biomarkers in Alzheimer's Disease: Trial
Nilotinib appears safe, well tolerated and affects biomarkers in Alzheimer's disease, according to the results of a clinical trial.
from Medindia Health News https://ift.tt/2XFrUW2
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment